SWOG clinical trial number
SWOG-9112
A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2
Closed
Phase
Accrual
3%
Abbreviated Title
A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2
Activated
07/15/1991
Closed
11/01/1992